GTCR looks to replicate Resonetics’ success with new investment Biocoat

GTCR managing director Luke Marker discusses the Chicago PE firm's recent investment in the maker of coatings for medical devices.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.